Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

23,630 total articles

BTCS Expands Imperium DeFi Strategy to Multi-Chain Operations

BTCS Expands Imperium DeFi Strategy to Multi-Chain Operations

BTCS Inc., a U.S.-based blockchain technology company, has expanded its Imperium decentralized finance (DeFi) business line onto Base, Coinbase's Ethereum Layer-2 network, facilitating faster and cheaper transactions. This multi-chain strategy allows BTCS to dynamically allocate digital assets across multiple networks, significantly increasing depl…

Blink Charging President and CEO, Mike Battaglia, to Present at the H.C. Wainwright 28th Annual Global Investment Conference on Monday, September 14, 2026

Blink Charging President and CEO, Mike Battaglia, to Present at the H.C. Wainwright 28th Annual Global Investment Conference on Monday, September 14, 2026

Blink Charging Co., a leading electric vehicle (EV) charging equipment provider, announced that its President and CEO Mike Battaglia will present at the H.C. Wainwright 28th Annual Global Investment Conference, discussing recent developments, market trends, and the company’s EnergyConnect announcement. The event is scheduled for September 14, 2026,…

Mobilicom Secures Follow-On Production Order from Asia-Based Tier-1 Robotics Customer for the Ground Control Station Solution

Mobilicom Secures Follow-On Production Order from Asia-Based Tier-1 Robotics Customer for the Ground Control Station Solution

Mobilicom Limited, a Nasdaq-listed provider of cybersecurity and communication solutions for drones and robotics, announced it has received a follow-on production order from a major Asia-based Tier-1 robotics manufacturer. This order focuses on Mobile Ground Control Stations, supporting ongoing deployment across the customer's military and industri…

Teva Begins Trading Ordinary Shares Directly on the NYSE, Marking a Milestone in its Pivot to Growth Strategy

Teva Begins Trading Ordinary Shares Directly on the NYSE, Marking a Milestone in its Pivot to Growth Strategy

Teva Pharmaceutical Industries Ltd. announced that its ordinary shares are now trading directly on the New York Stock Exchange under the ticker symbol TEVA, completing its transition from American Depositary Shares (ADS) to ordinary shares. This milestone aligns with Teva's Pivot to Growth strategy aimed at expanding its innovative medicines portfo…

Satellogic Supports HEO RPO Mission Operations

Satellogic Supports HEO RPO Mission Operations

Satellogic's Continuum-1 Earth observation satellite, recently acquired by HEO, successfully completed two extended proximity operation phases involving close inspection of a derelict Chinese rocket body in low-Earth orbit. This demonstration highlights the satellite's software capabilities beyond its original design, paving the way for sovereign s…

Upexi Amends BitGo Credit Facility

Upexi Amends BitGo Credit Facility

Upexi, Inc. amended its credit facility with BitGo Prime, lowering the interest rate from 11.5% to 7.5% and reducing collateral requirements. This is expected to save over $2 million annually in interest costs and provide greater financial flexibility, supporting its strategy to accumulate Solana tokens and enhance shareholder value.

Aqua Metals Signs Five-Year Copper and Aluminum Offtake LOI, Completing Commercial Coverage of Three Project Headwaters Product Streams

Aqua Metals Signs Five-Year Copper and Aluminum Offtake LOI, Completing Commercial Coverage of Three Project Headwaters Product Streams

Aqua Metals announced a non-binding five-year letter of intent with a leading Midwest metals recycler to offtake up to 100% of the copper and aluminum recovered from its Project Headwaters lithium-ion battery recycling facility. This agreement complements a previously announced lithium carbonate offtake, establishing commercial pathways for all mai…

Telomir Announces Research with The Ohio State University Demonstrating In-Vitro Anti-Cancer Activity in Human and Canine Osteosarcoma Models

Telomir Announces Research with The Ohio State University Demonstrating In-Vitro Anti-Cancer Activity in Human and Canine Osteosarcoma Models

Telomir Pharmaceuticals announced new research from The Ohio State University demonstrating that their compound Telomir-Zn inhibits cell growth effectively in human and canine osteosarcoma cell lines, suggesting potential for both veterinary and human therapeutic development. The company is advancing its triple-negative breast cancer (TNBC) program…

Nasus Pharma Announces FDA Clearance to Initiate Clinical Study of NS002 in the Treatment of Anaphylaxis

Nasus Pharma Announces FDA Clearance to Initiate Clinical Study of NS002 in the Treatment of Anaphylaxis

Nasus Pharma received FDA clearance to start clinical studies for NS002, an investigational intranasal epinephrine powder intended as a needle-free alternative to EpiPen for treating anaphylaxis. The pivotal study is planned for Q4 2026, with topline data expected in Q1 2027, aiming to address a $2 billion market by offering faster and more patient…

Live Oak Bank Named Official Business Bank of UNCW Athletics

Live Oak Bank Named Official Business Bank of UNCW Athletics

Live Oak Bank, a subsidiary of Live Oak Bancshares, Inc. (NYSE: LOB), has been named the Official Business Bank of UNCW Athletics under a multi-year agreement. This partnership enhances Live Oak's community presence, particularly in Wilmington, NC, and strengthens its connection with local small businesses and university alumni. The bank continues …

Linkage Global Signs Non-Binding Letter of Intent for Strategic PIPE Investment of Up to $20 Million from Capital Finance Limited

Linkage Global Signs Non-Binding Letter of Intent for Strategic PIPE Investment of Up to $20 Million from Capital Finance Limited

Linkage Global Inc., a US-listed company focused on AI-driven wellness solutions, has signed a non-binding letter of intent with Capital Finance Limited for up to $20 million in a two-tranche PIPE investment. The investment aims to accelerate development of AI-enabled wellness infrastructure and fund a strategic acquisition of an AI hardware manufa…

Radiopharm Theranostics Selected for Late-Breaking Oral Presentation of Positive Data from Interim Analysis of U.S. Phase 2b Imaging Trial of RAD101 at 2026 Society of Neuro-Oncology Annual Meeting

Radiopharm Theranostics Selected for Late-Breaking Oral Presentation of Positive Data from Interim Analysis of U.S. Phase 2b Imaging Trial of RAD101 at 2026 Society of Neuro-Oncology Annual Meeting

Radiopharm Theranostics revealed encouraging interim results from its Phase 2b trial of RAD101, a PET imaging agent targeting fatty acid synthase in suspected recurrent brain metastases. The 93% concordance with MRI and preliminary 86% sensitivity highlight RAD101's potential to improve diagnostic accuracy where current imaging methods are limited.…

Akebia Therapeutics Announces First Patient Dosed in Phase 2 Basket Trial of Ebribafusp in Rare Complement-Mediated Kidney Diseases

Akebia Therapeutics Announces First Patient Dosed in Phase 2 Basket Trial of Ebribafusp in Rare Complement-Mediated Kidney Diseases

Akebia Therapeutics has dosed the first patient in its open-label Phase 2 basket trial of ebribafusp, an investigational anti-C3d factor H fusion protein designed to inhibit complement activation in kidney tissue without suppressing the blood complement system. The trial targets rare kidney diseases including IgA nephropathy, lupus nephritis, and C…

Evaxion applies its AI-Immunology™ platform in autoimmune diseases

Evaxion applies its AI-Immunology™ platform in autoimmune diseases

Evaxion A/S has initiated experimental application of its AI-Immunology™ platform in autoimmune diseases by testing two novel treatment concepts – a tolerogenic vaccine and an autoantibody binder. These approaches aim to target underlying disease pathologies with high specificity, potentially leading to more effective and safer therapies than curre…

FactSet to Host Investor Day on November 10, 2026

FactSet to Host Investor Day on November 10, 2026

FactSet Research Systems Inc. has scheduled its Investor Day on November 10, 2026, in New York City and via webcast. The event will feature presentations from the CEO, CFO, and executive leadership about the company’s strategy, product roadmap, and financial outlook, including demonstrations of AI-driven solutions. Presentation materials will be av…

Oxford Lane Capital Corp. Provides August 2026 Net Asset Value Update

Oxford Lane Capital Corp. Provides August 2026 Net Asset Value Update

Oxford Lane Capital Corp. announced an unaudited estimate of its net asset value (NAV) per share for August 31, 2026, between $10.34 and $10.64. The company cautioned this estimate is preliminary, not approved by the board, and may materially differ from the September quarter-end NAV. The firm is a closed-end management investment company focused o…

etoro Reports Selected August Business Metrics

etoro Reports Selected August Business Metrics

eToro Group Ltd. released selected business metrics for August 2026 showing a 3% year-over-year increase in assets under administration to $20.2 billion and an 18% rise in funded accounts to 4.36 million. Total capital markets trades increased by 31%, though invested amount per trade declined by 29%. Crypto trades decreased by 4% with a significant…

CoinShares Announces First Half 2026 Results

CoinShares Announces First Half 2026 Results

CoinShares PLC released its H1 2026 financial results showing total revenue declined to $51.4 million from $80 million the prior year, driven by lower digital asset prices impacting assets under management (AUM), which fell to $5.5 billion from $7.4 billion at end-2025. Despite this, the company generated $27.6 million in net inflows, reflecting cl…